These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 4390116)

  • 1. The rate of dissolution of powdered griseofulvin at different stirring rates.
    Elworthy PH; Lipscomb FJ
    J Pharm Pharmacol; 1969 May; 21(5):273-6. PubMed ID: 4390116
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of ordered mixtures for improving the dissolution rate of low solubility compounds.
    Nyström C; Westerberg M
    J Pharm Pharmacol; 1986 Mar; 38(3):161-5. PubMed ID: 2871148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mechanistic study of griseofulvin dissolution into surfactant solutions under laminar flow conditions.
    Rao VM; Lin M; Larive CK; Southard MZ
    J Pharm Sci; 1997 Oct; 86(10):1132-7. PubMed ID: 9344170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of some non-ionic surfactants and a polyoxyethylene glycol on the dissolution rate of griseofulvin.
    Elworthy PH; Lipscomb FJ
    J Pharm Pharmacol; 1968 Dec; 20(12):923-33. PubMed ID: 4388332
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of in vivo dissolution behavior and GI transit of griseofulvin, a BCS class II drug.
    Fujioka Y; Metsugi Y; Ogawara K; Higaki K; Kimura T
    Int J Pharm; 2008 Mar; 352(1-2):36-43. PubMed ID: 18037251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissolution of slightly soluble powders under sink conditions. II. Griseofulvin powders.
    Ullah I; Cadwallader DE
    J Pharm Sci; 1971 Feb; 60(2):230-3. PubMed ID: 5572445
    [No Abstract]   [Full Text] [Related]  

  • 7. Dissolution rate of griseofulvin in bile salt solutions.
    de Smidt JH; Offringa JC; Crommelin DJ
    J Pharm Sci; 1991 Apr; 80(4):399-401. PubMed ID: 1865343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the melt granulation technique on the dissolution characteristics of griseofulvin.
    Yang D; Kulkarni R; Behme RJ; Kotiyan PN
    Int J Pharm; 2007 Feb; 329(1-2):72-80. PubMed ID: 17027207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmaceutical applications of solid dispersion systems: dissolution of griseofulvin-succinic acid eutectic mixture.
    Chiou WL; Niazi S
    J Pharm Sci; 1976 Aug; 65(8):1212-4. PubMed ID: 978439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of oral absorption of griseofulvin, a BCS class II drug, based on GITA model: utilization of a more suitable medium for in-vitro dissolution study.
    Fujioka Y; Kadono K; Fujie Y; Metsugi Y; Ogawara K; Higaki K; Kimura T
    J Control Release; 2007 Jun; 119(2):222-8. PubMed ID: 17442444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of spray drying and dispersing agent on surface and dissolution properties of griseofulvin micro and nanocrystals.
    Shah DA; Patel M; Murdande SB; Dave RH
    Drug Dev Ind Pharm; 2016 Nov; 42(11):1842-50. PubMed ID: 27080146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surfactant-mediated dissolution: contributions of solubility enhancement and relatively low micelle diffusivity.
    Balakrishnan A; Rege BD; Amidon GL; Polli JE
    J Pharm Sci; 2004 Aug; 93(8):2064-75. PubMed ID: 15236455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro dissolution of different brands of griseofulvin tablets.
    Khalafalla N
    Pharmazie; 1980; 35(9):555-8. PubMed ID: 7433509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of sodium dodecyl sulphate on the dissolution of poorly soluble drug into biorelevant medium from drug-surfactant discs.
    Madelung P; Ostergaard J; Bertelsen P; Jørgensen EV; Jacobsen J; Müllertz A
    Int J Pharm; 2014 Jun; 467(1-2):1-8. PubMed ID: 24594297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of the dissolution rate and oral absorption of a poorly water soluble drug by formation of surfactant-containing microparticles.
    Wong SM; Kellaway IW; Murdan S
    Int J Pharm; 2006 Jul; 317(1):61-8. PubMed ID: 16647232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissolution studies on paracetamol solidified melt prepared under different cooling rates.
    El-Banna HM; Ismail AA
    Pharmazie; 1975 Apr; 30(4):226-8. PubMed ID: 1153487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liquisolid technique to enhance and to sustain griseofulvin dissolution: effect of choice of non-volatile liquid vehicles.
    Elkordy AA; Essa EA; Dhuppad S; Jammigumpula P
    Int J Pharm; 2012 Sep; 434(1-2):122-32. PubMed ID: 22677418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The determination and interpretation of in-vitro dissolution behavior of pharmaceutical substances. 1. Powders, mixtures and granules].
    Voigt R; Eitz K; Bornschein M
    Pharmazie; 1987 Jan; 42(1):22-5. PubMed ID: 3575398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical effects of incorporated surfactants on stability and dissolution properties of amorphous polymeric dispersions.
    Al-Obaidi H; Lawrence MJ; Buckton G
    J Pharm Pharmacol; 2016 Nov; 68(11):1373-1383. PubMed ID: 27696396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interdependence of physiological surfactant and drug particle size on the dissolution behavior of water insoluble drugs.
    Lin SL; Menig J; Lachman L
    J Pharm Sci; 1968 Dec; 57(12):2143-8. PubMed ID: 5708358
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.